Mylan Gets Tentative FDA Approval For Singulair (Pharmaceutical Business Review) |

« FDA Approvals - Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Fiscal Year | Main | FDA Approvals - Bausch & Lomb Receives FDA Approval Of Besivance(TM), New Topical »

Mylan Gets Tentative FDA Approval For Singulair (Pharmaceutical Business Review)

Mylan Gets Tentative FDA Approval For Singulair (Pharmaceutical Business Review)
Mylan has declared that it has received tentative approval from FDA for its Abbreviated New Drug Application (ANDA) for Montelukast Sodium Tablets. Montelukast Sodium Tablets are the generic version of Merck and Co.'s Singulair, which is used for the treatment of asthma and allergy.

Additional information in: FDA Recalls

FDA News Search

Get Legal Help

Breaking FDA Recalls

Breaking FDA Approvals

Health Tip

It’s a little known fact that coffee benefits your health in a variety of important ways .

Food & Drug Categories

FDA News Archive

Subscribe to this site's RSS feed
FDA Resources

FDA News Site Map
FDA Online Resources
FDA Related Resources